Skip to content

Free delivery from two boxes·Subscription −10%, no commitmentSee the range

Account Cart
Bones and joints

Denosumab

anti-RANKL antibody · osteoporosis

Third-party option

What this medicine is for

Denosumab is a medication in the "anti-RANKL antibody (osteoporosis)" category. This medication strengthens bone solidity and reduces the risk of fracture.

For Denosumab in practice: Strengthens bone and reduces the risk of fracture. Its conditions of use depend on the situation, within the framework set by the doctor.

Under which brands it is found

In France, about 16 reimbursable presentations containing Denosumab are recorded. It comes under various trade names and in generic form.

  • Acvybra
  • Bomyntra
  • Conexxence
  • Denbrayce
  • Izamby
  • Jubbonti
  • Jubereq
  • Kefdensis
  • and other presentations

Original brand-name products and generics deliver the same active substance; the choice between them is made with your doctor or pharmacist.

Supplements to consider

None of our references covers Denosumab. What could be considered are 2 separate single-ingredient supplements, to be bought and taken each on its own.

Further reading

The literature on the nutrient

These studies concern the nutrient itself, its role, its forms, its bioavailability. They do not concern this medicine and assert no link between it and a nutrient requirement.

Talk about it in the community

A space to share among people who are affected: the early days, the habits built up over the years, what each person has found to live better with it. Shared experiences, nothing medical.

Join « Living with »

Related molecules

To explore within the « Bones and joints » family and its neighbours.

See the entire « Bones and joints » family · Back to the atlas